Pharma doesn't have a document problem. It has a decision latency problem.
Every clinical trial runs on documents — protocols, amendments, SAPs, consent forms. When a protocol changes, the questions that matter most (what changed, does it affect enrollment or safety, who signed off) are still answered by hand. SmartIntel is being built to close that gap, and we're validating it now with real clinical trial documents.
Clinical trial protocols change constantly — and every change carries three questions that regulators, sponsors, and IRBs all eventually ask: what exactly changed between this version and the last, does it impact enrollment, dosing, or safety, and who reviewed it and can that decision be defended later, under inspection. Today, those answers live in PDFs, emails, and spreadsheets. Teams re-read entire protocols, compare versions by hand, and hope nothing material gets missed. That's not a technology gap. It's a risk and accountability gap — and in a regulated environment, an accountability gap is a compliance liability waiting for an inspector to find it.
SmartIntel is a decision intelligence layer for regulated documents, starting with a deliberately narrow wedge: clinical trial protocol amendments and their downstream impact. This isn't positioned as "AI that reads documents" — OCR, LLMs, and RAG pipelines are commodity components anyone can assemble. The actual hard problem is what happens after the document is read: knowing which version is the source of truth with certainty, explaining why an answer is correct with evidence attached rather than just asserted, making uncertainty visible instead of quietly hiding it in a confident-sounding summary, and keeping humans in control with an audit-ready review trail behind every decision. In a regulated environment, the value was never in getting an answer fast — it's in getting a defensible one. SmartIntel is being validated against real clinical trial documents now, ahead of a full enterprise deployment. Core capability already built includes an OCR-powered amendment diff comparing old protocol version to new with version control, an immutable audit timeline that's inspection-ready at any point, AI gap detection with risk scoring per amendment, consent obligation mapping linked to active subject records, a lock-and-sign workflow with reviewer audit trail, and private Azure deployment so clinical data never leaves the client's environment.
Explore SmartIntel →What changed.
Have a similar problem?
Bring us the constraint. We'll scope the shortest path to a working system.